The drug is well tolerated and has a low incidence of harmful side effects.<ref name="pmid9098664"/> However, development of bacterial resistance under therapy is a frequent occurrence and makes fosfomycin unsuitable for sustained therapy of severe infections. It is not recommended for children and those over 75 years old.<ref>{{cite web |url=http://www.drugs.com/uk/monuril-sachets-3g-leaflet.html |title=MONURIL SACHETS 3G |accessdate=May 26, 2014}}</ref>
